Dreman Value Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$5K Hold
132
﹤0.01% 440
2017
Q4
$6K Hold
132
﹤0.01% 421
2017
Q3
$7K Hold
132
﹤0.01% 387
2017
Q2
$6K Buy
+132
New +$6.31K ﹤0.01% 401
2017
Q1
Sell
-1,030
Closed -$42K 357
2016
Q4
$42K Sell
1,030
-19,174
-95% -$755K 0.02% 276
2016
Q3
$772K Hold
20,204
0.47% 93
2016
Q2
$846K Buy
20,204
+18,334
+980% +$752K 0.52% 74
2016
Q1
$75K Buy
+1,870
New +$75.1K 0.01% 296
2015
Q4
Sell
-1,102
Closed -$52K 379
2015
Q3
$52K Hold
1,102
0.01% 372
2015
Q2
$55K Hold
1,102
﹤0.01% 380
2015
Q1
$54K Hold
1,102
﹤0.01% 368
2014
Q4
$50K Buy
+1,102
New +$53.5K ﹤0.01% 393

Other funds holding SNY

Dreman Value Management's SNY Position: Q1 2018 in Review

Dreman Value Management held its Sanofi (SNY) position steady in Q1 2018 at 132 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #440.

Dreman Value Management first reported a position in SNY in Q4 2014 and has held it in 12 quarters since. The position peaked at $846K in Q2 2016. 487 funds tracked by Wall St. Rank hold SNY as of Q1 2018.

  • Dreman Value Management held 132 shares of Sanofi worth $5K as of Q1 2018.
  • Dreman Value Management left its Sanofi share count unchanged in Q1 2018.
  • Sanofi made up ﹤0.01% of Dreman Value Management's portfolio in Q1 2018, its #440 holding.
  • Dreman Value Management first reported a position in Sanofi in Q4 2014 and has held it in 12 quarters since.
  • Dreman Value Management's Sanofi position peaked at $846K in Q2 2016.
  • 487 funds tracked by Wall St. Rank held Sanofi as of Q1 2018.

Based on Dreman Value Management's 13F filing for Q1 2018, filed 2 May 2018.